// App-Quantinova.ai

: Comprehensive Profiling of B7 Checkpoint Inhibitors and Associated ImmuneResponse in Pancreatic Neuroendocrine Neoplasms (PanNENs)

Researchers

Presenter

  • H. Yan

Principal Investigators

  • B. Bassam

  • K. Zhang

  • F. Guo

  • J. Chen

  • Z. Lu

  • M. Tu

  • J. Wei

  • W. Gao

  • K. Jiang

  • J. Wu

  • Y. Miao

Medical Centers

  • Nanjing Medical University/The First Affiliated Hospital, Pancreas Center, Nanjing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Neuroendocrine tumors

Biomarkers

  • B7 homolog 3

  • Cluster of Differentiation 4

  • Cluster of Differentiation 2AP

  • Programmed cell death 1 ligand 2

  • Programmed death-ligand 1

  • Cluster of differentiation 86

  • Cluster of differentiation 8A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved